MONISTAT DERM CREAM 2 %
MICONAZOLE NITRATE : 2 % · DIN 02126567 · INSIGHT PHARMACEUTICALS, LLC
Health Canada status: MARKETED
What is MONISTAT DERM CREAM?
MONISTAT DERM CREAM 2 % contains MICONAZOLE NITRATE : 2 %. It is listed in the Health Canada Drug Product Database under DIN 02126567, held by INSIGHT PHARMACEUTICALS, LLC, supplied as CREAM for TOPICAL administration. Health Canada currently lists it as marketed, status dated 30-Aug-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is MONISTAT DERM CREAM used for?
Topical treatment of dermatophytes, Candida infections, and mixed fungal infections. Used with vaginal ovules/suppositories for extensive vulvovaginal candidiasis.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02126567 |
|---|---|
| Brand name | MONISTAT DERM CREAM |
| Generic / active ingredient | MICONAZOLE NITRATE : 2 % |
| Manufacturer | INSIGHT PHARMACEUTICALS, LLC |
| Strength | 2 % |
| Dosage form | CREAM |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D01AC02 MICONAZOLE |
| AHFS class | 84:04.08.08 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 30-Aug-2012 |
| Original market date | 1980-12-31 00:00:00 |
How is it administered?
Apply to affected area twice daily (morning and evening). Massage gently. Treat Candida for 2 weeks and dermatophytes for 1 month to reduce recurrence.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at controlled room temperature (15 °C - 30 °C).
How is it supplied?
15-gram or 30-gram laminate tube in a paperboard carton.
Contraindications
Hypersensitivity to this drug or to any ingredient in the formulation, including any non-medicinal ingredient, or component of the container.
Warnings and precautions
Discontinue if sensitization or irritation occurs. Avoid eye contact. Reduces effectiveness of latex condoms/diaphragms (do not use during therapy and for 3 days after).
What can be used instead?
Other Canadian products sharing ATC code D01AC02 MICONAZOLE. 3 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MICATIN MICONAZOLE NITRATE CREAM 2% USP | 2 % | CREAM | WELLSPRING PHARMACEUTICAL CANADA CORP | MARKETED | DIN 02085852 |
| MICATIN POWDER SPRAY - UNSCENTED 2% | 2 % | AEROSOL | WELLSPRING PHARMACEUTICAL CANADA CORP | MARKETED | DIN 02230304 |
Who else supplies MICONAZOLE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. MICONAZOLE appears in 785 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.